480 related articles for article (PubMed ID: 8666822)
1. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the function of the first component of complement by human C1q receptor.
van den Berg RH; Faber-Krol M; van Es LA; Daha MR
Eur J Immunol; 1995 Aug; 25(8):2206-10. PubMed ID: 7664783
[TBL] [Abstract][Full Text] [Related]
3. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
4. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
5. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent C1 activation by E. coli.
Tenner AJ; Ziccardi RJ; Cooper NR
J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
[TBL] [Abstract][Full Text] [Related]
7. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
8. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
9. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
11. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
12. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q.
Lu JH; Thiel S; Wiedemann H; Timpl R; Reid KB
J Immunol; 1990 Mar; 144(6):2287-94. PubMed ID: 2313094
[TBL] [Abstract][Full Text] [Related]
13. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
14. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation.
Chen A; Gaddipati S; Hong Y; Volkman DJ; Peerschke EI; Ghebrehiwet B
J Immunol; 1994 Aug; 153(4):1430-40. PubMed ID: 8046223
[TBL] [Abstract][Full Text] [Related]
15. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.
Krumdieck R; Höök M; Rosenberg LC; Volanakis JE
J Immunol; 1992 Dec; 149(11):3695-701. PubMed ID: 1431141
[TBL] [Abstract][Full Text] [Related]
16. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
18. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activation of the classical pathway of complement by human neutrophil defensins.
van den Berg RH; Faber-Krol MC; van Wetering S; Hiemstra PS; Daha MR
Blood; 1998 Nov; 92(10):3898-903. PubMed ID: 9808583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]